("UKOG" or the "Company")
Employee Benefit Trust Share Subscription
Consequently, the Company's EBT trustees, Altum Trustees Ltd ("Trustees"), have today subscribed for 476,897,760 ordinary shares in the Company ("EBT Shares") at a price per share of
The EBT Shares shall be held in the EBT on trust pending the transfer upon vesting (or exercise, as the case may be) of any awards granted by the Company's Remuneration Committee to eligible employees and directors under the terms and vesting criteria of the Company's SIP. Details of the grant of any future awards of EBT Shares will be notified upon determination by the Company's Remuneration Committee of the beneficiaries of such awards, however no such determination has been made for the time being.
Admission
Application has been made for EBT Shares, numbering 476,897,760 ordinary shares in total, to be admitted to trading on AIM ("Admission"). Admission is expected to take place at 8.00 a.m. on or around 9 August 2024.
Following Admission, the total voting rights in the Company will be 8,644,353,833 ordinary shares. Following admission of the 2,000,000,000 placing shares on 27 August 2024 (as announced on 5 August 2024) and admission of the EBT Shares, the total voting rights in the Company will be 10,644,353,388 ordinary shares. Shareholders may use these figures as the denominator by which they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure, Guidance and Transparency Rules.
For further information, please contact:
Stephen Sanderson / Guzyal Mukhametzhanova Tel: 01483 941493
Zeus Capital Limited (Nominated Adviser and Broker)
James Joyce / James Bavister / Andrew de Andrade Tel: 0203 829 5000
CMC Markets (Joint Broker)
Douglas Crippen Tel: 0203 003 8632
Communications
Brian Alexander Tel: 01483 941493
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.